Stock listing

Frankfurt:9HA Elicio Therapeutics, Inc. Aktie

German listing (Frankfurt) of Elicio Therapeutics, Inc. · home listing NASDAQ:ELTX

Follow Elicio Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · FWB:9HA

€1.50 EUR +0.02 (+1.4%)

Close on Oct 30, 2026

Day range
€1.50 – €1.56 EUROct 30, 2026
Market cap
€40.64M EURAt the close on Oct 30, 2026 · price × 27.09M shares outstanding
Elicio Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ELTX · Home$1.68 USD-0.07 (-4.0%)183,462$1.74$1.78$1.655$1.75Close on Oct 30, 2026
Frankfurt:9HA€1.50 EUR+0.02 (+1.4%)—€1.55€1.56€1.50€1.48Close on Oct 30, 2026
Ticker
Frankfurt:9HA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Elicio Therapeutics, Inc. news

Financings

  • Registered direct offering of shares of common stock

    Aug 13, 2026

    Closed: US$15M in the latest tranche · Titan Partners, a division of American Capital Partners +1

    Dealers: Titan Partners, a division of American Capital Partners (lead), B. Riley Securities, Inc.

    Use of proceeds: Support the planned Phase 1 development of ELI-002 7P in metastatic pancreatic cancer and advance the pipeline

    Closed Jul 6, 2026 · Closed Aug 13, 2026

Read by 6ix AI from the company's releases

Decks

Elicio Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
22 in the last 12 months · 34 in all · newest Oct 23, 2026 · oldest 2025
Decks
15 decks · latest September 2026

Where Elicio Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ELTX · Home listingNASDAQUnited StatesUSD
LS Exchange:A3CY4JLS ExchangeGermanyEUR
BOATS:ELTXBOATSUnited StatesUSD
Lang & Schwarz:A3CY4JLang & SchwarzGermanyEUR
gettex:9HAgettexGermanyEUR
Dusseldorf:9HADusseldorfGermanyEUR
Frankfurt:9HA · This pageFrankfurtGermanyEUR
Munich:9HAMunichGermanyEUR
Tradegate:9HATradegateGermanyEUR

Log in to ask 6ix AI your own questions about Elicio Therapeutics, Inc.